Myeongmun Rosuvastatin Calcium Tablet 10 mg

Adult dose

The initial dose is 5 mg once daily, and if greater LDL cholesterol reduction is needed, the maintenance dose can be adjusted accordingly. The maintenance dose is 10 mg once daily, and most patients are managed at this dose. The maintenance dose should be adjusted appropriately based on LDL cholesterol levels, treatment goals, and the patient's response at intervals of 4 weeks or more, and may be increased up to a maximum of 20 mg once daily.

This medication should not be used in certain patients. For example, individuals who are allergic to this drug, those with severely impaired liver function, those with muscle disorders, those taking certain immunosuppressants, patients with severe renal impairment, women who are pregnant or breastfeeding, and women who are capable of becoming pregnant but do not use proper contraception should not take this medication. Additionally, liver function and muscle status should be regularly monitored before and during treatment with this medication, and those with a history of alcohol abuse or liver disease should exercise particular caution. If symptoms such as muscle pain or weakness occur, a doctor should be notified immediately, and if necessary, the medication can be discontinued. This medication contains lactose, so individuals with lactose intolerance or certain genetic metabolic disorders should not take it. This medication can interact with other drugs, so any other medications being taken should be disclosed to a physician or pharmacist. In particular, co-administration with certain antibiotics, antifungal agents, immunosuppressants, and fibrates may increase the risk of muscle-related side effects. Women who are pregnant or breastfeeding should not take this medication, and women who are capable of becoming pregnant should use appropriate contraception. If pregnancy is confirmed, the use of this medication should be immediately discontinued. In the case of overdose, since there is no specific antidote, immediate medical attention should be sought for appropriate treatment and evaluation. This medication may rarely cause side effects such as skin rash, headache, dizziness, gastrointestinal disturbance, muscle pain, and malaise; if serious skin reactions or liver dysfunction symptoms occur, immediate medical evaluation is required. Caution is needed as dizziness may occur while driving or operating machinery. When administering this medication to children and adolescents, assessment of growth and sexual development is necessary, and dose adjustment and caution are required.

Serious side effects

Allergic reactions including urticaria and angioedema, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), rhabdomyolysis, myopathy, immune-mediated necrotizing myopathy, severe muscle weakness, ocular muscle weakness, dyspnea, cough, hepatitis, jaundice, fatal and non-fatal liver failure, acute renal failure, anuria, chest tightness

Mild side effects

• Headache
• dizziness
• constipation
• nausea
• abdominal pain
• itching
• muscle pain
• weakness
• diarrhea
• fatigue

This medication should be stored in a tightly closed container to protect it from air and moisture. The storage temperature should be kept at room temperature between 1°C and 30°C. This will help maintain the effectiveness and safety of the medication.

Appearance

Pink round film-coated tablets

Package unit

For domestic use - 30 tablets/bottle, for export - 30 tablets/box [(10 tablets/PTP*3)]